Profile data is unavailable for this security.
About the company
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
- Revenue in SEK (TTM)18.19m
- Net income in SEK-3.27m
- Incorporated2004
- Employees8.00
- LocationInhalation Sciences Sweden ABHalsovagen 7, Novum Floor 6, Elevator EHUDDINGE 141 57SwedenSWE
- Phone+46 85 468845846
- Websitehttps://www.inhalation.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VibroSense Dynamics AB | 2.08m | -7.61m | 22.55m | -- | -- | 3.01 | -- | 10.86 | -0.5156 | -0.5156 | 0.1325 | 0.292 | 0.1889 | 0.1441 | 9.78 | -- | -69.18 | -46.24 | -85.81 | -53.08 | 94.02 | 85.61 | -366.26 | -551.22 | 3.09 | -- | 0.00 | -- | 22.89 | 29.61 | 6.88 | -- | -5.74 | -- |
Level Bio AB (publ) | 23.85m | -11.38m | 23.77m | 13.00 | -- | 2.99 | -- | 0.9967 | -0.1794 | -0.1794 | 0.3762 | 0.1256 | 1.14 | 4.08 | 5.71 | 1,834,817.00 | -54.52 | -6.39 | -79.18 | -10.51 | -0.1479 | -- | -47.69 | -4.09 | 0.9424 | -- | 0.00 | -- | -23.10 | 7.83 | -326.08 | -- | -4.64 | -- |
Medimi AB | 3.90m | -13.85m | 27.17m | 6.00 | -- | 2.44 | -- | 6.97 | -0.0182 | -0.0182 | 0.0048 | 0.0103 | 0.2463 | 0.6773 | 3.76 | 650,148.30 | -87.48 | -81.87 | -105.06 | -93.93 | 51.85 | 4.06 | -355.15 | -840.93 | 4.00 | -65.57 | 0.2183 | -- | 75.13 | 280.69 | 7.52 | -- | -- | -- |
Chordate Medical Holding AB (publ) | 1.11m | -28.09m | 27.82m | 3.00 | -- | 1.00 | -- | 24.98 | -0.0906 | -0.0906 | 0.0036 | 0.0568 | 0.0289 | -0.3708 | 9.70 | 371,183.30 | -72.99 | -91.98 | -86.88 | -122.85 | 160.96 | 209.52 | -2,522.81 | -3,295.75 | 3.43 | -- | 0.00 | -- | 799.63 | 0.6511 | -4.45 | -- | -- | -- |
Invent Medic Sweden AB | 6.91m | -8.34m | 30.58m | 8.00 | -- | 8.86 | -- | 4.43 | -0.2176 | -0.2176 | 0.1798 | 0.0801 | 0.5673 | 2.14 | 3.79 | 863,296.30 | -68.50 | -97.56 | -109.24 | -121.06 | 77.26 | 77.16 | -120.76 | -490.98 | 0.4874 | -16.36 | 0.3007 | -- | 115.97 | 177.53 | 28.77 | -- | -22.61 | -- |
Miris Holding AB (publ) | 16.26m | -11.31m | 31.85m | 10.00 | -- | -- | -- | 1.96 | -0.2734 | -0.2734 | 0.393 | -0.1286 | 0.8539 | -0.1129 | 7.34 | 1,625,800.00 | -59.40 | -59.61 | -186.31 | -111.08 | 102.12 | 86.68 | -69.57 | -103.61 | 0.2251 | -11.97 | -- | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
Neodynamics AB (publ) | 327.31k | -87.19m | 31.89m | -- | -- | 0.6669 | -- | 97.44 | -37.52 | -37.52 | 0.0042 | 1.47 | 0.0045 | 5.47 | 1.48 | -- | -120.15 | -53.18 | -158.59 | -61.85 | -12,573.30 | -- | -26,637.31 | -17,680.11 | 1.14 | -22.78 | 0.00 | -- | 138.18 | -- | -24.36 | -- | -45.17 | -- |
Inhalation Sciences Sweden AB | 18.19m | -3.27m | 44.90m | 8.00 | -- | 3.69 | -- | 2.47 | -0.21 | -0.21 | 1.32 | 0.8014 | 1.16 | 0.9413 | 7.49 | 2,273,250.00 | -20.80 | -27.93 | -35.65 | -43.82 | 81.25 | 71.13 | -17.96 | -48.02 | 2.68 | -2.92 | 0.071 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
Scandinavian ChemoTech AB | 4.11m | -19.26m | 47.71m | 6.00 | -- | 4.69 | -- | 11.60 | -1.28 | -1.28 | 0.2641 | 0.424 | 0.2327 | 0.3224 | 1.36 | 685,500.00 | -108.95 | -87.29 | -108.95 | -118.55 | 39.00 | 252.05 | -468.27 | -2,122.77 | -- | -15.73 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
Glycorex Transplantation AB (publ) | 31.00m | -29.54m | 64.94m | 15.00 | -- | 1.68 | -- | 2.10 | -0.40 | -0.40 | 0.4197 | 0.5485 | 0.3978 | 0.7283 | 4.60 | 1,347,652.00 | -37.91 | -11.30 | -47.48 | -13.17 | 84.79 | 91.60 | -95.30 | -33.24 | 1.20 | -118.90 | 0.2046 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
Codelab Capital AS | -99.37bn | -99.37bn | 65.92m | 200.00 | -- | 0.4739 | -- | -- | -- | -- | -- | 0.633 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
iZafe Group AB | 5.00m | -32.78m | 66.00m | 7.00 | -- | 3.03 | -- | 13.19 | -0.133 | -0.133 | 0.0201 | 0.0791 | 0.109 | 1.24 | 2.46 | 714,857.10 | -71.38 | -52.17 | -82.09 | -69.40 | -10.99 | -- | -655.02 | -487.50 | 0.6947 | -- | 0.1174 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |